查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1372799

負壓傷口治療市場－2018-2028年全球產業規模、佔有率、趨勢、機會和預測，按產品、傷口類型、最終用途、地區、競爭預測和機會細分，2018-2028F

Negative Pressure Wound Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Wound Type, By End-use, By Region, By Competition Forecast & Opportunities, 2018-2028F
出版日期: | 出版商: TechSci Research | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022年全球負壓傷口治療市場估值已達23.4億美元，並有望大幅成長，預計到2028年年複合成長率(CAGR)為6.47%。全球負壓傷口治療(NPWT)市場涉及透過施加負壓來促進傷口癒合和控制滲出物來治療各種傷口和潰瘍的醫療技術和產品。 NPWT 由於其在加速傷口癒合、降低感染風險和改善患者治療效果方面的功效而在醫療保健領域引起了廣泛關注。

主要市場促進因素

人口老化

市場概況
預測期 2024-2028
2022 年市場規模 23.4億美元
2028 年市場規模 33.9億美元
2023-2028 年年複合成長率 6.47%
成長最快的細分市場 醫院
最大的市場 北美洲

全球醫療保健格局正在經歷轉變，部分原因是人口老化。隨著世界各地人們的壽命越來越長，他們的慢性健康狀況也越來越普遍，導致對先進醫療的需求更大。負壓傷口治療 (NPWT) 是一種顯著成長的治療方法。世界人口正以前所未有的速度老化。據聯合國稱，到2050 年，全球60 歲及以上人口預計將達到21 億，幾乎是2017 年的兩倍。這種人群變化意義重大，因為老化往往伴隨著可能導致慢性傷口的健康問題，包括糖尿病、循環系統問題和壓瘡。老化是一個自然過程，但它也與慢性健康問題的可能性增加有關。隨著年齡的成長，糖尿病、週邊血管疾病和肥胖等慢性疾病變得更加普遍。這些情況可能會導致傷口癒合緩慢或不癒合，這通常很難處理。 NPWT 已成為有效處理這些複雜傷口的重要工具。老年患者經常出現複雜的傷口，需要專門護理。 NPWT 提供了一種非侵入性的先進傷口管理解決方案，可顯著改善癒合過程。它能夠去除多餘的液體、降低感染風險並促進組織肉芽形成，這使其成為治療老年患者的醫療保健專業人員的一個有吸引力的選擇。治療老年人口中的慢性傷口的費用可能會很高。延長住院時間、頻繁門診、併發症風險都會增加醫療支出。 NPWT 可以透過促進傷口更快癒合來幫助減輕經濟負擔，從而降低住院時間和整體護理成本。由於慢性傷口限制了活動能力和獨立性，老年人口的生活品質常常下降。 NPWT 可以透過加速傷口閉合和減輕疼痛來提高這些患者的生活品質。因此，患者可以更快地恢復活動能力和獨立性。

新興市場

全球負壓傷口治療 (NPWT) 市場在多種因素的推動下取得了顯著成長，包括醫療技術的進步和對 NPWT 益處的認知的提高。這一成長的一個值得注意的貢獻者是新興市場的蓬勃發展。這些地區的特點是經濟快速發展和醫療基礎設施不斷擴大，擁有將 NPWT 市場推向新高度的巨大潛力。新興市場通常位於發展中國家，其特徵是經濟成長強勁、醫療保健支出不斷增加以及中產階級人口不斷成長。這些市場正在見證醫療保健服務的變革，先進醫療治療和技術的取得管道不斷改善。因此，它們為醫療保健相關行業（包括 NPWT 市場）提供了前景廣闊的前景。新興市場正經歷糖尿病、肥胖症和心血管疾病等慢性病的激增。這些情況與傷口不癒合的風險較高有關，這使得 NPWT 成為傷口管理和加速癒合的重要工具。隨著這些疾病盛行率的增加，對 NPWT 的需求也增加。在醫療保健支出增加、現代醫療實踐的採用以及人口老化不斷加劇等因素的推動下，新興市場的外科手術數量不斷增加。手術傷口通常受益於 NPWT，從而導致對該技術的更高需求。新興市場正在大力投資擴大其醫療基礎設施，包括建立現代化的醫院和診所。隨著醫療機構數量的不斷增加，採用 NPWT 技術的機會更大。隨著新興市場醫療保健素養的提高，醫療保健專業人員和患者都更加了解 NPWT 等先進傷口護理解決方案。這種意識的提高推動了需求和採用率。 NPWT 雖然最初被認為昂貴，但從長遠來看可能是一種具有成本效益的解決方案，特別是在住院費用和術後護理費用可能很高的新興市場。這種成本效益正在鼓勵醫療保健提供者和政策制定者接受 NPWT。

慢性病增加

全球負壓傷口治療 (NPWT) 市場正在經歷顯著成長，而這項擴張背後的關鍵促進因素之一是全球慢性病的驚人成長。這些疾病包括糖尿病、肥胖、心血管疾病等，通常會導致慢性傷口，需要 NPWT 等複雜的傷口護理解決方案。慢性病已在全球流行，構成了重大的公共衛生挑戰。世界衛生組織 (WHO) 報告稱，慢性病約佔全球死亡人數的 71%，成為全球死亡的主要原因。這種令人震驚的趨勢是由多種因素所驅動的，包括久坐的生活方式、不良的飲食選擇、人口老化和遺傳傾向。慢性疾病，特別是糖尿病和周圍血管疾病，通常會導致慢性傷口。這些傷口癒合緩慢且容易出現併發症，例如感染和組織壞死。 NPWT 已成為有效管理這些傷口的寶貴工具。 NPWT 透過創造一個刺激血流、減少水腫和去除多餘液體的受控環境來促進傷口癒合。對於慢性傷口患者，NPWT 可以顯著加速癒合過程並改善整體結果。慢性傷口患者感染和其他併發症的風險較高，這可能導致住院時間延長和醫療費用增加。 NPWT 可以減輕這些風險，從長遠來看是一種具有成本效益的解決方案。糖尿病患者特別容易出現足部潰瘍，這是糖尿病的常見併發症。 NPWT 已證明其在治療糖尿病足潰瘍方面的有效性，糖尿病足潰瘍因癒合緩慢且可能需要截肢而臭名昭著。隨著受慢性病影響的人數持續增加，潛在的 NPWT 患者數量也不斷增加。患者群體的擴大是市場成長的重要動力。

外科手術

全球負壓傷口治療（NPWT）市場一直在經歷大幅成長，而這種擴張背後的驅動力之一是外科手術的持續發展。隨著手術技術變得更加先進和廣泛，對 NPWT 等創新傷口護理解決方案的需求不斷增加。負壓傷口治療，也稱為真空輔助閉合（VAC）療法，是一種用於加速傷口癒合的複雜醫療方法。它涉及透過連接到專用敷料的真空幫浦向傷口施加受控負壓。這個過程可以去除多餘的液體，刺激血液流動，並促進健康組織的生長，從而改善傷口癒合效果。現代醫學見證了複雜外科手術的激增，包括器官移植、重建手術和減肥手術。這些手術通常會導致較大的手術傷口，需要 NPWT 等專門的傷口護理解決方案才能實現最佳癒合。微創手術技術因其恢復時間短和疤痕最小而受到歡迎。然而，即使是這些手術也可能需要 NPWT 才能達到最佳癒合，特別是在切口較大或出現併發症的情況下。由於事故和不可預見的醫療事件，創傷和緊急手術呈上升趨勢。 NPWT 可以成為緊急手術期間管理傷口護理的重要工具，從而降低併發症的風險。

主要市場挑戰

初始成本高

NPWT 市場面臨的主要挑戰之一是與該技術相關的相對較高的初始成本。對於醫療機構來說，NPWT 所需的設備和消耗品可能非常昂貴，因此是一項重大投資。規模較小且資金不足的醫療機構可能會發現難以負擔這些前期費用。

報銷問題

NPWT 報銷政策和做法在不同國家和地區之間可能存在很大差異。在某些地區，醫療保健提供者面臨不一致的報銷率或複雜的計費流程。這可能會產生不確定性並阻礙 NPWT 的採用。

技術壁壘

儘管 NPWT 技術已取得顯著進步，但仍有改進的空間。需要更小、更攜帶的設備來改善患者的活動能力和舒適度。此外，確保 NPWT 系統對使用者友好並且能夠被醫療保健專業人員在各種環境中有效使用是一個持續的挑戰。

全球供應鏈中斷

COVID-19 大流行凸顯了全球供應鏈的脆弱性。 NPWT 依賴消耗品和設備的及時供應，供應鏈中斷可能會影響患者護理。製造商和醫療機構需要確保強大的供應鏈來滿足需求。

主要市場趨勢

攜帶式和穿戴式設備

NPWT 市場最令人興奮的發展之一是攜帶式和穿戴式裝置的出現。傳統的 NPWT 系統通常體積龐大，並且需要患者保持不動。然而，穿戴式 NPWT 裝置提供了更高的移動性和舒適度，使患者能夠在接受治療的同時繼續進行日常活動。這些緊湊、方便用戶使用的設備有望徹底改變傷口護理並提高患者的依從性。

互聯醫療生態系統

將 NPWT 系統整合到互聯的醫療保健生態系統中是即將出現的另一個重要趨勢。這些智慧型設備將使醫療保健提供者能夠遠端監控患者的進展，確保有效地進行治療。即時資料收集和分析將增強決策能力，有可能降低併發症的風險並改善患者的治療結果。

高級敷料材料

敷料材料的創新將在 NPWT 市場的未來中發揮關鍵作用。製造商不斷研究開發能夠更好地貼合傷口形狀、增強液體管理並提高患者舒適度的新型材料。這些材料旨在使 NPWT 對於患者和醫療保健提供者更加有效和方便。

生物活性 NPWT 解決方案

生物活性 NPWT 解決方案旨在透過促進組織再生和減少發炎來加速傷口癒合。這些新一代療法可能會結合生長因子、抗菌劑和其他生物活性物質，以增強傷口癒合過程。隨著該領域研究的進展，生物活性 NPWT 可能成為治療複雜傷口的標準方法。

細分市場洞察

產品洞察

2022 年，傳統設備類別佔據了最大的收入佔有率，這主要歸因於其高成本和不斷成長的採用率。這些系統需要住院，並且由於依賴重型罐子而對於家庭護理使用來說是不切實際的。這些設備的租賃選項預計將提高購買力有限的發展中國家的 NPWT 利用率。

傷口類型見解

根據傷口類型類別，壓瘡細分市場將在 2022 年成為全球負壓傷口治療市場的主導者，主要是因為所需的治療持續時間延長。患有壓瘡的患者通常需要更長的住院時間，從而導致醫療費用增加。推動這一成長的另一個因素是其在治療褥瘡等與壓力相關的傷口方面的新興應用。

相反，糖尿病足潰瘍領域預計在預測期內將經歷最顯著的年複合成長率，這主要是由於其在 NPWT 治療方面取得的顯著成功以及糖尿病的高盛行率。糖尿病足潰瘍是最常見的慢性傷口形式，NPWT 在加速此類損傷的癒合過程中發揮關鍵作用。其他傷口類別包括動脈潰瘍和手術傷口等。

區域洞察

2022 年，由於該地區醫療保健支出的增加和高度先進的醫療保健基礎設施，北美地區佔據了收入的最大部分。因此，無論是在醫院環境中還是在家庭護理中，NPWT 設備的採用顯著增加。同時，在亞太地區，預計未來幾年年複合成長率可望實現。這項預測主要源於燒傷等創傷事件的不斷增加，從而刺激了該地理區域對此類治療的需求。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球負壓傷口治療市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（常規 NPWT、拋棄式 NPWT）
    • 依傷口類型（糖尿病足潰瘍、腿部靜脈潰瘍、壓瘡、燒傷、其他）
    • 依最終用途（醫院、家庭護理、其他）
    • 按地區
    • 按公司分類 (2022)
  • 產品市場地圖
    • 按產品分類
    • 按傷口類型
    • 按最終用途
    • 按地區

第 6 章：北美負壓傷口治療市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（常規 NPWT、拋棄式 NPWT）
    • 依傷口類型（糖尿病足潰瘍、腿部靜脈潰瘍、壓瘡、燒傷、其他）
    • 依最終用途（醫院、家庭護理、其他）
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲負壓傷口治療市場前景

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（常規 NPWT、拋棄式 NPWT）
    • 依傷口類型（糖尿病足潰瘍、腿部靜脈潰瘍、壓瘡、燒傷、其他）
    • 依最終用途（醫院、家庭護理、其他）
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙

第 8 章：亞太地區負壓傷口治療市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（常規 NPWT、拋棄式 NPWT）
    • 依傷口類型（糖尿病足潰瘍、腿部靜脈潰瘍、壓瘡、燒傷、其他）
    • 依最終用途（醫院、家庭護理、其他）
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國

第 9 章：南美洲負壓傷口治療市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（常規 NPWT、拋棄式 NPWT）
    • 依傷口類型（糖尿病足潰瘍、腿部靜脈潰瘍、壓瘡、燒傷、其他）
    • 依最終用途（醫院、家庭護理、其他）
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲負壓傷口治療市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（常規 NPWT、拋棄式 NPWT）
    • 依傷口類型（糖尿病足潰瘍、腿部靜脈潰瘍、壓瘡、燒傷、其他）
    • 依最終用途（醫院、家庭護理、其他）
    • 按國家/地區
  • MEA：國家分析
    • 南非負壓傷口治療
    • 沙烏地阿拉伯負壓傷口治療
    • 阿拉伯聯合大公國負壓傷口治療
    • 科威特負壓傷口治療

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第14章：競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
  • SWOT分析
    • Acelity LP Inc
    • Talley's Group Ltd
    • Smith & Nephew PLC
    • Devon Health Services Inc
    • Molnlycke Health Care AB
    • Medela AG
    • DeRoyal Industries Inc
    • ConvaTec Inc
    • Cardinal Health Inc
    • PAUL HARTMANN AG

第 15 章：策略建議

第 16 章：關於我們與免責聲明

簡介目錄
Product Code: 16231

The Global Negative Pressure Wound Therapy Market has reached a valuation of USD 2.34 billion in 2022 and is poised for substantial growth, with an expected Compound Annual Growth Rate (CAGR) of 6.47% through 2028. The Global Negative Pressure Wound Therapy (NPWT) Market pertains to the medical technologies and products employed in the treatment of diverse wounds and ulcers by applying negative pressure to promote wound healing and manage exudate. NPWT has garnered significant attention in the healthcare sector due to its efficacy in expediting wound healing, lowering the risk of infection, and enhancing patient outcomes.

Key Market Drivers

Aging Population

Market Overview
Forecast Period2024-2028
Market Size 2022USD 2.34 Billion
Market Size 2028USD 3.39 Billion
CAGR 2023-20286.47%
Fastest Growing SegmentHospitals
Largest MarketNorth America

The global healthcare landscape is undergoing a transformation, driven in part by the aging population. As people worldwide are living longer, they are also experiencing an increased prevalence of chronic health conditions, leading to a greater demand for advanced medical treatments. One such treatment that has seen significant growth is Negative Pressure Wound Therapy (NPWT). The world's population is aging at an unprecedented rate. According to the United Nations, by 2050, the global population aged 60 and above is expected to reach 2.1 billion, nearly double what it was in 2017. This demographic shift is significant because aging is often accompanied by health issues that can lead to chronic wounds, including diabetes, circulatory problems, and pressure ulcers. Aging is a natural process, but it is also associated with an increased likelihood of chronic health conditions. Chronic diseases such as diabetes, peripheral vascular disease, and obesity become more prevalent with age. These conditions can lead to slow-healing or non-healing wounds, which are often challenging to manage. NPWT has emerged as a crucial tool in addressing these complex wounds effectively. Aging patients often present with complex wounds that require specialized care. NPWT provides a non-invasive and advanced wound management solution that can significantly improve the healing process. Its ability to remove excess fluid, reduce infection risk, and promote tissue granulation makes it an attractive option for healthcare professionals dealing with elderly patients. The cost of treating chronic wounds in aging populations can be substantial. Extended hospital stays, frequent outpatient visits, and the risk of complications all contribute to healthcare expenditures. NPWT can help reduce the economic burden by facilitating faster wound healing, thus lowering hospitalization durations and the overall cost of care. The elderly population often faces diminished quality of life due to chronic wounds that limit mobility and independence. NPWT can enhance the quality of life for these patients by expediting wound closure and reducing pain. As a result, patients can regain their mobility and independence more quickly.

Emerging Markets

The Global Negative Pressure Wound Therapy (NPWT) market has been witnessing remarkable growth, driven by several factors, including advancements in medical technology and increased awareness about the benefits of NPWT. One noteworthy contributor to this growth is the burgeoning presence of emerging markets. These regions, characterized by rapid economic development and an expanding healthcare infrastructure, hold immense potential to propel the NPWT market to new heights. Emerging markets, often found in developing countries, are characterized by dynamic economic growth, increasing healthcare expenditures, and a growing middle-class population. These markets are witnessing a transformation in healthcare delivery, with improved access to advanced medical treatments and technologies. As a result, they offer a promising landscape for healthcare-related industries, including the NPWT market. Emerging markets are experiencing a surge in chronic diseases, such as diabetes, obesity, and cardiovascular disorders. These conditions are associated with a higher risk of non-healing wounds, making NPWT a vital tool in wound management and accelerating healing. As the prevalence of these diseases increases, so does the demand for NPWT. Emerging markets are witnessing a rise in surgical procedures, driven by factors such as increased healthcare spending, the adoption of modern medical practices, and a growing aging population. Surgical wounds often benefit from NPWT, leading to a higher demand for this technology. Emerging markets are investing heavily in expanding their healthcare infrastructure, including the establishment of modern hospitals and clinics. With a growing number of healthcare facilities, there is a greater opportunity for the adoption of NPWT technology. As healthcare literacy improves in emerging markets, both healthcare professionals and patients become more aware of advanced wound care solutions like NPWT. This increased awareness drives demand and adoption rates. NPWT, although initially considered expensive, can be a cost-effective solution in the long run, especially in emerging markets where the cost of hospital stays, and post-operative care can be high. This cost-effectiveness is encouraging healthcare providers and policymakers to embrace NPWT.

Rise in Chronic Diseases

The Global Negative Pressure Wound Therapy (NPWT) market is experiencing remarkable growth, and one of the key drivers behind this expansion is the alarming increase in chronic diseases worldwide. These conditions, which include diabetes, obesity, cardiovascular diseases, and more, often lead to chronic wounds that require sophisticated wound care solutions like NPWT. Chronic diseases have reached epidemic proportions globally, posing a significant public health challenge. The World Health Organization (WHO) reports that chronic diseases account for approximately 71% of all global deaths, making them the leading cause of mortality worldwide. This alarming trend is driven by several factors, including sedentary lifestyles, poor dietary choices, aging populations, and genetic predisposition. Chronic diseases, particularly diabetes and peripheral vascular diseases, often lead to chronic wounds. These wounds are slow to heal and prone to complications, such as infections and tissue necrosis. NPWT has emerged as an invaluable tool for managing these wounds effectively. NPWT promotes wound healing by creating a controlled environment that stimulates blood flow, reduces edema, and removes excess fluids. For patients with chronic wounds, NPWT can significantly accelerate the healing process and improve overall outcomes. Patients with chronic wounds are at higher risk of infections and other complications, which can lead to prolonged hospital stays and increased healthcare costs. NPWT can mitigate these risks, making it a cost-effective solution in the long run. Diabetic patients are particularly prone to foot ulcers, a common complication of diabetes. NPWT has demonstrated its effectiveness in managing diabetic foot ulcers, which are notorious for their slow healing and potential for amputation. As the number of individuals affected by chronic diseases continues to rise, so does the pool of potential NPWT patients. This expansion of the patient base is a significant driver of market growth.

Surgical Procedures

The Global Negative Pressure Wound Therapy (NPWT) market has been experiencing substantial growth, and one of the driving forces behind this expansion is the continuous evolution of surgical procedures. As surgical techniques become more advanced and widespread, the demand for innovative wound care solutions like NPWT is on the rise. Negative Pressure Wound Therapy, also known as vacuum-assisted closure (VAC) therapy, is a sophisticated medical approach used to expedite wound healing. It involves applying controlled negative pressure to a wound through a vacuum pump connected to a specialized dressing. This process removes excess fluids, stimulates blood flow, and encourages the growth of healthy tissue, leading to improved wound healing outcomes. Modern medicine has seen a surge in complex surgical procedures, including organ transplants, reconstructive surgeries, and bariatric surgeries. These operations often result in larger surgical wounds that require specialized wound care solutions like NPWT for optimal healing. Minimally invasive surgical techniques have gained popularity due to their reduced recovery times and minimal scarring. However, even these procedures may necessitate NPWT for optimal healing, especially in cases where larger incisions are made, or complications arise. Trauma and emergency surgeries are on the rise, driven by accidents and unforeseen medical events. NPWT can be a critical tool in managing wound care during emergency procedures, reducing the risk of complications.

Key Market Challenges

High Initial Costs

One of the primary challenges faced by the NPWT market is the relatively high initial costs associated with the technology. The equipment and consumables required for NPWT can be expensive for healthcare facilities, making it a significant investment. Smaller and underfunded healthcare institutions may find it challenging to afford these upfront costs.

Reimbursement Issues

NPWT reimbursement policies and practices can vary greatly between countries and regions. In some areas, healthcare providers struggle with inconsistent reimbursement rates or complicated billing processes. This can create uncertainty and hinder the adoption of NPWT.

Technological Barriers

While NPWT technology has advanced significantly, there is still room for improvement. Smaller, more portable devices are needed to improve patient mobility and comfort. Additionally, ensuring that NPWT systems are user-friendly and can be effectively used by healthcare professionals in various settings is an ongoing challenge.

Global Supply Chain Disruptions

The COVID-19 pandemic underscored the vulnerability of global supply chains. NPWT relies on the timely availability of consumables and equipment, and disruptions in the supply chain can impact patient care. Manufacturers and healthcare facilities need to ensure a robust supply chain to meet demand.

Key Market Trends

Portable and Wearable Devices

One of the most exciting developments in the NPWT market is the emergence of portable and wearable devices. Traditional NPWT systems are often bulky and require patients to remain immobile. However, wearable NPWT devices offer increased mobility and comfort, enabling patients to continue with their daily activities while receiving therapy. These compact, user-friendly devices are expected to revolutionize wound care and enhance patient compliance.

Connected Healthcare Ecosystem

The integration of NPWT systems into connected healthcare ecosystems is another significant trend on the horizon. These smart devices will enable healthcare providers to remotely monitor patients' progress, ensuring that the therapy is administered effectively. Real-time data collection and analysis will enhance decision-making, potentially reducing the risk of complications and improving patient outcomes.

Advanced Dressing Materials

Innovations in dressing materials are set to play a pivotal role in the NPWT market's future. Manufacturers are continuously researching and developing novel materials that can better conform to wound shapes, enhance fluid management, and improve patient comfort. These materials aim to make NPWT more effective and convenient for both patients and healthcare providers.

Bioactive NPWT Solutions

Bioactive NPWT solutions are designed to accelerate wound healing by promoting tissue regeneration and reducing inflammation. These next-generation therapies may incorporate growth factors, antimicrobial agents, and other bioactive substances to enhance the wound healing process. As research in this field progresses, bioactive NPWT may become a standard approach for complex wounds.

Segmental Insights

Product Insights

In 2022, the conventional devices category held the largest share of revenue, primarily attributed to their high cost and growing adoption. These systems necessitate hospital admission and are impractical for homecare use due to their reliance on heavy canisters. The availability of rental options for these devices is projected to boost NPWT utilization in developing nations where purchasing power is limited.

On the other hand, the single-use NPWT devices segment is anticipated to experience a lucrative Compound Annual Growth Rate (CAGR) in the coming years. This is because they find extensive applicability in home care settings, prompting major companies to emphasize enhancing their cost-efficiency. This strategic focus has proven to be an additional advantage for single-use NPWT devices, particularly in developing countries.

Wound Type Insights

Based on the category of Wound Type, the Pressure Ulcers segment emerged as the dominant player in the global market for negative pressure wound therapy in 2022 primarily due to the extended treatment duration required. Patients dealing with pressure ulcers typically need longer hospital stays, resulting in increased healthcare expenses. Another contributing factor to this growth is its emerging application for addressing pressure-related wounds like bedsores.

Conversely, the diabetic foot ulcers segment is expected to experience the most significant CAGR during the forecast period, mainly due to its remarkable success in NPWT treatment and the high prevalence of diabetes. Diabetic foot ulcers represent the most common form of chronic wounds, and NPWT plays a pivotal role in expediting the healing process for such injuries. Other wound categories include arterial ulcers and surgical wounds, among others.

Regional Insights

In 2022, North America claimed the most significant portion of revenue due to the increased healthcare spending and the highly advanced healthcare infrastructure within the region. Consequently, there has been a notable uptick in the adoption of NPWT devices, both in hospital settings and for homecare purposes. Meanwhile, in the Asia Pacific region, a promising CAGR is expected in the upcoming years. This projection primarily stems from the growing occurrence of traumatic incidents like burns, which subsequently fuels the demand for such therapy in this geographical area.

Key Market Players

  • Acelity LP Inc
  • Talley's Group Ltd
  • Smith & Nephew PLC
  • Devon Health Services Inc
  • Molnlycke Health Care AB
  • Medela AG
  • DeRoyal Industries Inc
  • ConvaTec Inc
  • Cardinal Health Inc
  • PAUL HARTMANN AG

Report Scope:

In this report, the Global Negative Pressure Wound Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Negative Pressure Wound Therapy Market, By Product:

  • Conventional NPWT
  • Single-Use NPWT

Negative Pressure Wound Therapy Market, By Wound Type:

  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Pressure Ulcers
  • Burn Wounds
  • Others

Negative Pressure Wound Therapy Market, By End-use:

  • Hospitals
  • Homecare
  • Others

Negative Pressure Wound Therapy Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Negative Pressure Wound Therapy Market.

Available Customizations:

  • Global Negative Pressure Wound Therapy market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Negative Pressure Wound Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Conventional NPWT, Single-Use NPWT)
    • 5.2.2. By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Burn Wounds, Others)
    • 5.2.3. By End-use (Hospitals, Homecare, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Product Market Map
    • 5.3.1. By Product
    • 5.3.2. By Wound Type
    • 5.3.3. By End-use
    • 5.3.4. By Region

6. North America Negative Pressure Wound Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Conventional NPWT, Single-Use NPWT)
    • 6.2.2. By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Burn Wounds, Others)
    • 6.2.3. By End-use (Hospitals, Homecare, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Negative Pressure Wound Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Wound Type
        • 6.3.1.2.3. By End-use
    • 6.3.2. Canada Negative Pressure Wound Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Wound Type
        • 6.3.2.2.3. By End-use
    • 6.3.3. Mexico Negative Pressure Wound Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Wound Type
        • 6.3.3.2.3. By End-use

7. Europe Negative Pressure Wound Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Conventional NPWT, Single-Use NPWT)
    • 7.2.2. By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Burn Wounds, Others)
    • 7.2.3. By End-use (Hospitals, Homecare, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Negative Pressure Wound Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Wound Type
        • 7.3.1.2.3. By End-use
    • 7.3.2. United Kingdom Negative Pressure Wound Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Wound Type
        • 7.3.2.2.3. By End-use
    • 7.3.3. France Negative Pressure Wound Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Wound Type
        • 7.3.3.2.3. By End-use
    • 7.3.4. Italy Negative Pressure Wound Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Wound Type
        • 7.3.4.2.3. By End-use
    • 7.3.5. Spain Negative Pressure Wound Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Wound Type
        • 7.3.5.2.3. By End-use

8. Asia-Pacific Negative Pressure Wound Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Conventional NPWT, Single-Use NPWT)
    • 8.2.2. By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Burn Wounds, Others)
    • 8.2.3. By End-use (Hospitals, Homecare, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Negative Pressure Wound Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Wound Type
        • 8.3.1.2.3. By End-use
    • 8.3.2. Japan Negative Pressure Wound Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Wound Type
        • 8.3.2.2.3. By End-use
    • 8.3.3. India Negative Pressure Wound Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Wound Type
        • 8.3.3.2.3. By End-use
    • 8.3.4. Australia Negative Pressure Wound Therapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Wound Type
        • 8.3.4.2.3. By End-use
    • 8.3.5. South Korea Negative Pressure Wound Therapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Wound Type
        • 8.3.5.2.3. By End-use

9. South America Negative Pressure Wound Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Conventional NPWT, Single-Use NPWT)
    • 9.2.2. By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Burn Wounds, Others)
    • 9.2.3. By End-use (Hospitals, Homecare, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Negative Pressure Wound Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Wound Type
        • 9.3.1.2.3. By End-use
    • 9.3.2. Argentina Negative Pressure Wound Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Wound Type
        • 9.3.2.2.3. By End-use
    • 9.3.3. Colombia Negative Pressure Wound Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Wound Type
        • 9.3.3.2.3. By End-use

10. Middle East and Africa Negative Pressure Wound Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Conventional NPWT, Single-Use NPWT)
    • 10.2.2. By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Burn Wounds, Others)
    • 10.2.3. By End-use (Hospitals, Homecare, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Negative Pressure Wound Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Wound Type
        • 10.3.1.2.3. By End-use
    • 10.3.2. Saudi Arabia Negative Pressure Wound Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Wound Type
        • 10.3.2.2.3. By End-use
    • 10.3.3. UAE Negative Pressure Wound Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Wound Type
        • 10.3.3.2.3. By End-use
    • 10.3.4. Kuwait Negative Pressure Wound Therapy Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product
        • 10.3.4.2.2. By Wound Type
        • 10.3.4.2.3. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Product Offerings
  • 14.3. Recent Developments
  • 14.4. Financials (As Reported)
  • 14.5. Key Personnel
  • 14.6. SWOT Analysis
    • 14.6.1. Acelity LP Inc
    • 14.6.2. Talley's Group Ltd
    • 14.6.3. Smith & Nephew PLC
    • 14.6.4. Devon Health Services Inc
    • 14.6.5. Molnlycke Health Care AB
    • 14.6.6. Medela AG
    • 14.6.7. DeRoyal Industries Inc
    • 14.6.8. ConvaTec Inc
    • 14.6.9. Cardinal Health Inc
    • 14.6.10. PAUL HARTMANN AG

15. Strategic Recommendations

16. About Us & Disclaimer